Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119189) titled 'An exploratory study on the diagnosis of primary and metastatic lesions of solid tumors using 68GA-labeled peptides' on Feb. 24.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The First Affiliated Hospital of Jinan University
Condition:
Tumor
Intervention:
Gold Standard:Immunohistochemical Pathology Results
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-24
Target Sample Size: Target condition:30;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=306695
Di...